{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lyndhurst",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81858",
      "recalling_firm": "Amerigen Pharmaceuticals Inc.",
      "address_1": "9 Polito Ave Ste 900",
      "address_2": "",
      "postal_code": "07071-3410",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 4 wholesalers and 2 retail accounts who may have further distributed the products.",
      "recall_number": "D-0345-2019",
      "product_description": "Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason Pharmaceuticals, Inc., Irvine, CA, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ ---- NDC 43975-256-14",
      "product_quantity": "771 bottles",
      "reason_for_recall": "Failed Dissolution Specifications",
      "recall_initiation_date": "20181220",
      "center_classification_date": "20181226",
      "termination_date": "20191217",
      "report_date": "20190102",
      "code_info": "Lot # 18E031, exp 05/2020",
      "more_code_info": ""
    }
  ]
}